Amy W. Schulman

Fall Term 2012

Lecturer on Law

Appointments

• Executive Vice President and General Counsel, Pfizer Inc
• President and General Manager, Pfizer Nutrition

Additional Information

Ms. Schulman will teach The Strategic Management of a Mass Tort: Legal & Business Challenges Arising from the COX-2 Inhibitor Litigations in the Fall 2012 term.

Biographical Statement

Amy W. Schulman joined Pfizer as General Counsel in June 2008, and played a key role in the negotiations leading up to what became the largest pharmaceutical acquisition in history with Pfizer's $68 billion purchase of Wyeth Pharmaceuticals. At Pfizer, Ms. Schulman heads a division of professionals who handle some of the most complex, challenging legal matters facing the company and devised a groundbreaking approach to engaging outside counsel that transforms the traditional billable-hour model. In 2010, in addition to her role as the General Counsel, Ms. Schulman was asked to lead Pfizer Nutrition-a $2 billion, global business. She successfully led the $11.85 billion sale of Pfizer Nutrition to Nestle in 2012. Ms. Schulman also serves as Executive Sponsor of Pfizer's Global Women's Council, where she helps shape efforts to increase diversity and expand opportunities for both women and men across the company. Before joining Pfizer, Ms. Schulman was a senior partner at DLA Piper from 1997-2008. She built and led the firm's mass tort and class-action practice, with clients including GE Healthcare, Cisco, Wyeth, Philip Morris, Kraft Foods and Pfizer. A Phi Beta Kappa graduate of Wesleyan University, Ms. Schulman earned her J.D. from Yale Law School in 1989. She serves on the Board of Directors of the International Association of Infant Food Manufacturers, Wesleyan University and the Brooklyn Academy of Music.